|
CN104922076A
|
|
Exenatide sustained release microsphere and preparation method thereof
|
|
CN104745565A
|
|
Polyethyleneglycol-modified recombinant metarginase
|
|
CN104745597A
|
|
Method for efficiently expressing recombinant liraglutide
|
|
CN104946659A
|
|
Preparation method of recombinant human growth hormone and preparation method of PEGylation modification substance
|
|
CN104745553A
|
|
Recombinant human hyaluronidase, preparation method thereof and adopted polyethylene glycol covalently modified compound and method
|
|
CN104745564A
|
|
Polyethylene glycol modified L-asparaginasum as well as preparation method and application thereof
|
|
CN101928704A
|
|
Polyethylene glycol modifier of aspergillus flavus urate oxidase and preparation method thereof
|
|
CN101875923A
|
|
Fusion protein of human serum albumin and urate oxidase and preparation method thereof
|
|
CN101089178A
|
|
Beta-lactamase and its prepn process and application
|
|
CN101007077A
|
|
Composite for oral cavity containing natural plant extracts
|
|
CN101003802A
|
|
Method for preparing maturation peptide of morphogenesis protein - 2 of human bones
|
|
CN1864744A
|
|
Pharmaceutical preparation containing urate oxidase
|
